Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFR, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM, respectively
仅供研究使用。 我们不向患者出售。
化学信息
名称 | Ponatinib (AP24534) |
Iupac 化学名称 | 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
同义词 | N/A |
英文同义词 | N/A |
分子式 | C29H27F3N6O |
分子量 | 532.56 |
Smile | N=1C=C(N2N=CC=CC21)C#CC=2C=C(C(=O)NC1=CC(=C(C=C1)CN1CCN(CC1)C)C(F)(F)F)C=CC2C |
InChiKey | PHXJVRSECIGDHY-UHFFFAOYSA-N |
InChi | InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) |
Cas号 | 943319-70-8 |
相关CAS号 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |